Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29382
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPANG, Jing-
dc.contributor.authorMARAIS, A. David-
dc.contributor.authorBLOM, Dirk J.-
dc.contributor.authorBRICE, Brigitte C.-
dc.contributor.authorSILVA, Pamela R. S.-
dc.contributor.authorJANNES, Cinthia E.-
dc.contributor.authorPEREIRA, Alexandre C.-
dc.contributor.authorHOOPER, Amanda J.-
dc.contributor.authorRAY, Kausik K.-
dc.contributor.authorSANTOS, Raul D.-
dc.contributor.authorWATTS, Gerald F.-
dc.date.accessioned2018-11-21T17:00:32Z-
dc.date.available2018-11-21T17:00:32Z-
dc.date.issued2018-
dc.identifier.citationATHEROSCLEROSIS, v.277, p.470-476, 2018-
dc.identifier.issn0021-9150-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29382-
dc.description.abstractBackground and aims: Familial hypercholesterolaemia (FH) is the commonest monogenic disorder that accelerates atherosclerotic cardiovascular disease. We compared and contrasted the characteristics of patients from three specialist centres in the southern hemisphere. Methods: Adult index-cases with molecularly diagnosed heterozygous FH attending specialist lipid centres in Cape Town, Perth and Sao Paulo were studied. Myocardial infarction, revascularisation, hypertension, diabetes, smoking and lipid-lowering treatment were recorded at the time of diagnosis and compared across the three centres. Results: The spectrum of genetic variants causative of FH was significantly different in patients attending the centres in South Africa compared with Australia and Brazil. Hypertension and diabetes were more prevalent in Brazilian and Australian patients, than in South African patients, but the frequency of smoking was significantly greater in South Africa than the other two centres (p<0.01). Age, male sex and smoking were significant independent predictors of coronary artery disease (CAD) in all three countries (p<0.05). Conclusions: Patients with FH in three specialist centres in the southern hemisphere exhibit a high prevalence of non-cholesterol cardiovascular disease risk factors. Older age, male sex and smoking were more common among subjects with CAD. In all three countries, there should be vigorous programmes for the control of risk factors beyond good control of hypercholesterolaemia among patients with FH. Promotion of a healthy lifestyle, especially anti-smoking advice, is of paramount importance. (c) 2018 Published by Elsevier B.V.-
dc.description.sponsorshipInternational Atherosclerosis Society-
dc.description.sponsorshipPfizer [10839501]-
dc.language.isoeng-
dc.publisherELSEVIER IRELAND LTD-
dc.relation.ispartofAtherosclerosis-
dc.rightsrestrictedAccess-
dc.subjectFamilial hypercholesterolaemia-
dc.subjectHeterozygous-
dc.subjectSouth Africa-
dc.subjectAustralia-
dc.subjectBrazil-
dc.subject.othercoronary-artery-disease-
dc.subject.otherrisk-factors-
dc.subject.othercardiovascular-disease-
dc.subject.othergeneral-population-
dc.subject.otherldl-cholesterol-
dc.subject.otherprevalence-
dc.subject.othercare-
dc.subject.othermutation-
dc.subject.otherindividuals-
dc.subject.otherexperience-
dc.titleHeterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER IRELAND LTD-
dc.identifier.doi10.1016/j.atherosclerosis.2018.06.822-
dc.identifier.pmid30270087
dc.subject.wosCardiac & Cardiovascular Systems-
dc.subject.wosPeripheral Vascular Disease-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalPANG, Jing:Univ Western Australia, Sch Med, Fac Hlth & Med Sci, Perth, WA, Australia-
hcfmusp.author.externalMARAIS, A. David:Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; Natl Hlth Lab Serv, Cape Town, South Africa-
hcfmusp.author.externalBLOM, Dirk J.:Univ Cape Town, Fac Hlth Sci, Dept Med, Div Lipidol, Cape Town, South Africa; Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa-
hcfmusp.author.externalBRICE, Brigitte C.:Univ Cape Town, Fac Hlth Sci, Dept Med, Div Lipidol, Cape Town, South Africa; Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa-
hcfmusp.author.externalHOOPER, Amanda J.:Univ Western Australia, Sch Med, Fac Hlth & Med Sci, Perth, WA, Australia; Royal Perth Hosp, PathWest Lab Med WA, Dept Clin Biochem, Perth, WA, Australia; Fiona Stanley Hosp Network, Perth, WA, Australia-
hcfmusp.author.externalRAY, Kausik K.:Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England-
hcfmusp.author.externalWATTS, Gerald F.:Univ Western Australia, Sch Med, Fac Hlth & Med Sci, Perth, WA, Australia; Royal Perth Hosp, Dept Cardiol, Cardiometab Serv, Lipid Disorders Clin, Perth, WA, Australia-
hcfmusp.description.beginpage470-
hcfmusp.description.endpage476-
hcfmusp.description.volume277-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000445908000070-
hcfmusp.origem.id2-s2.0-85050134824-
hcfmusp.publisher.cityCLARE-
hcfmusp.publisher.countryIRELAND-
hcfmusp.relation.referenceAbul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000-
hcfmusp.relation.referenceAllard MD, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-65-
hcfmusp.relation.referenceAlonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024-
hcfmusp.relation.referenceBeliard S, 2014, ATHEROSCLEROSIS, V234, P136, DOI 10.1016/j.atherosclerosis.2014.02.021-
hcfmusp.relation.referenceBell DA, 2015, ATHEROSCLEROSIS, V239, P93, DOI 10.1016/j.atherosclerosis.2014.12.036-
hcfmusp.relation.referenceBenn M, 2016, EUR HEART J, V37, P1384, DOI 10.1093/eurheartj/ehw028-
hcfmusp.relation.referenceBenn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563-
hcfmusp.relation.referenceChan DC, 2015, INT J CARDIOL, V201, P633, DOI 10.1016/j.ijcard.2015.08.146-
hcfmusp.relation.referenceCiveira F, 2005, ARTERIOSCL THROM VAS, V25, P1960, DOI 10.1161/01.ATV.0000177811.14176.2b-
hcfmusp.relation.referencede Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791-
hcfmusp.relation.referencedeGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381-
hcfmusp.relation.referenceEllis KL, 2016, J CLIN LIPIDOL, V10, P1329, DOI 10.1016/j.jacl.2016.08.011-
hcfmusp.relation.referenceFirth JC, 2008, SAMJ S AFR MED J, V98, P99-
hcfmusp.relation.referenceHadfield SG, 2008, ANN CLIN BIOCHEM, V45, P199, DOI 10.1258/acb.2007.007078-
hcfmusp.relation.referenceHarada-Shiba M, 2012, J ATHEROSCLER THROMB, V19, P1019, DOI 10.5551/jat.14159-
hcfmusp.relation.referenceHaralambos K, 2016, CURR OPIN LIPIDOL, V27, P367, DOI 10.1097/MOL.0000000000000325-
hcfmusp.relation.referenceHooper AJ, 2012, ATHEROSCLEROSIS, V224, P430, DOI 10.1016/j.atherosclerosis.2012.07.030-
hcfmusp.relation.referenceHopkins PN, 2001, AM J CARDIOL, V87, P547, DOI 10.1016/S0002-9149(00)01429-6-
hcfmusp.relation.referenceJannes CE, 2015, ATHEROSCLEROSIS, V238, P101, DOI 10.1016/j.atherosclerosis.2014.11.009-
hcfmusp.relation.referenceJansen ACM, 2004, J INTERN MED, V256, P482, DOI 10.1111/j.1365-2796.2004.01405.x-
hcfmusp.relation.referenceKamstrup PR, 2013, EUR HEART J, V34, P334-
hcfmusp.relation.referenceMata N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-94-
hcfmusp.relation.referenceMiserez AR, 2000, ATHEROSCLEROSIS, V148, P433, DOI 10.1016/S0021-9150(99)00470-0-
hcfmusp.relation.referenceMundal L, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001236-
hcfmusp.relation.referenceNeil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764-
hcfmusp.relation.referenceNolting PRWD, 2003, J INTERN MED, V253, P161-
hcfmusp.relation.referenceNordestgaard BG, 2017, EUR HEART J, V38, P1580, DOI 10.1093/eurheartj/ehx136-
hcfmusp.relation.referencePang J, 2016, J ATHEROSCLER THROMB, V23, P505, DOI 10.5551/jat.34108-
hcfmusp.relation.referencePang J, 2016, J PEDIATR-US, V170, P315, DOI 10.1016/j.jpeds.2015.11.019-
hcfmusp.relation.referencePijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014-
hcfmusp.relation.referenceRaal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523-
hcfmusp.relation.referenceSEFTEL HC, 1980, BRIT MED J, V281, P633, DOI 10.1136/bmj.281.6241.633-
hcfmusp.relation.referenceThompson G. R., 2017, EUR HEART J, P1162-
hcfmusp.relation.referenceVallejo-Vaz AJ, 2016, ATHEROSCLEROSIS SUPP, V22, P1, DOI 10.1016/j.atherosclerosissup.2016.10.001-
hcfmusp.relation.referenceVickery AW, 2017, HEART LUNG CIRC, V26, P450, DOI 10.1016/j.hlc.2016.09.012-
hcfmusp.relation.referenceWald DS, 2016, NEW ENGL J MED, V375, P1628, DOI 10.1056/NEJMoa1602777-
hcfmusp.relation.referenceWatts GF, 2016, J ATHEROSCLER THROMB, V23, P891, DOI 10.5551/jat.35949-
hcfmusp.relation.referenceWatts GF, 2015, INT J CARDIOL, V185, P69, DOI 10.1016/j.ijcard.2015.03.027-
hcfmusp.relation.referenceWatts GF, 2014, INT J CARDIOL, V171, P309, DOI 10.1016/j.ijcard.2013.11.025-
dc.description.indexMEDLINE-
dc.identifier.eissn1879-1484-
hcfmusp.citation.scopus4-
hcfmusp.scopus.lastupdate2022-06-17-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/13
LIM/13 - Laboratório de Genética e Cardiologia Molecular

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_PANG_Heterozygous_familial_hypercholesterolaemia_in_specialist_centres_in_South_2018.PDF
  Restricted Access
publishedVersion (English)540.89 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.